Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. A. Markovich
Chemotherapy of Metastatic Neuroendocrine Tumors With Aranose in Monoregimen and in Combination With Capecitabine and Temozolomide.
Malignant tumours
Sunitinib in Pancreatic Neuroendocrine Tumors. Clinical Case
Medical Council
Related publications
Randomized Trial of the Combination of Lomeguatrib and Temozolomide Compared With Temozolomide Alone in Chemotherapy Naive Patients With Metastatic Cutaneous Melanoma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Identification of Primary Tumors in Patients Presenting With Metastatic Gastroenteropancreatic Neuroendocrine Tumors
Surgery
Surgery
Systemic Chemotherapy With FOLFOX in Metastatic Grade 1/2 Neuroendocrine Cancer
Molecular and Clinical Oncology
Cancer Research
Oncology
Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer
Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
Combination of 6-Thioguanine, Capecitabine, and Celecoxib With Temozolomide or Lomustine for Recurrent High-Grade Glioma
Journal of Neuro-Oncology
Cancer Research
Oncology
Neurology
Patterns of Care Among Real‐World Patients With Metastatic Neuroendocrine Tumors
Oncologist
Cancer Research
Medicine
Oncology
Chemotherapy-Associated Steatohepatitis With Temozolomide and Dexamethasone
Canadian Journal of Neurological Sciences
Medicine
Neurology
Combination Chemotherapy in Metastatic Breast Cancer
BMJ
Temozolomide Combined With Capecitabine in the Treatment of Mixed Neuroendocrine Carcinoma of the Lung With Poor Tolerance After Repeated Radiochemotherapy: A Case Report and Literature Review
OncoTargets and Therapy
Oncology
Pharmacology
